Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Heart Rhythm. 2017 Jul;14(7):1087-1096. doi: 10.1016/j.hrthm.2017.02.030. Epub 2017 Mar 2.
The end point of current catheter-based ablation approaches for the treatment of atrial fibrillation (AF) is the elimination of all the possible triggers with the least amount of ablation necessary. Once all the triggers have been eliminated, the incremental value of any additional lesion sets remains to be proven. Pulmonary vein (PV) isolation is the cornerstone of catheter ablation approaches for eliminating AF triggers. However, up to 11% of patients demonstrate reproducible sustained AF initiation from non-PV foci. In these patients, triggers can typically be elicited using standardized induction protocols, which include cardioversion of spontaneous and/or induced AF and infusion of high-dose isoproterenol. Non-PV triggers typically arise from discrete anatomical structures that include the mitral and tricuspid periannular regions, the crista terminalis and Eustachian ridge, the interatrial septum, the left atrial (LA) posterior wall, the left atrial appendage (LAA), and other thoracic veins such as the superior vena cava, the coronary sinus, and the ligament of Marshall. Localization of non-PV foci involves a detailed analysis of specific intra-atrial activation sequences using multipolar catheters in standard atrial locations coupled with information from the surface electrocardiogram P wave when possible. Multipolar catheters positioned along the coronary sinus and crista terminalis/superior vena cava region together with direct recordings from the right and left PVs allow a quick localization of non-PV foci. Elimination of non-PV triggers by means of focal ablation at the site of origin or isolation of arrhythmogenic structures (eg, LA posterior wall or superior vena cava) has been associated with improved arrhythmia-free survival.
目前用于治疗心房颤动 (AF) 的基于导管的消融方法的终点是用尽可能少的消融来消除所有可能的触发因素。一旦消除了所有的触发因素,任何额外的病变集的增量价值仍有待证明。肺静脉 (PV) 隔离是消除 AF 触发因素的导管消融方法的基石。然而,高达 11%的患者表现出可重现的持续性 AF 起始于非 PV 焦点。在这些患者中,触发因素通常可以使用标准化的诱导方案来诱发,包括自发性和/或诱发性 AF 的心脏复律以及高剂量异丙肾上腺素的输注。非 PV 触发因素通常来自离散的解剖结构,包括二尖瓣和三尖瓣环周区域、冠状窦口和峡部、房间隔、左心房 (LA) 后壁、左心耳 (LAA) 和其他胸静脉,如上腔静脉、冠状窦和Marshall 韧带。非 PV 焦点的定位涉及使用标准心房位置的多极导管对特定的房间内激活序列进行详细分析,并尽可能结合来自体表心电图 P 波的信息。沿冠状窦和冠状窦口/上腔静脉区域放置的多极导管以及直接记录右和左 PV 可以快速定位非 PV 焦点。通过在起源部位进行局灶性消融或隔离心律失常结构(例如,LA 后壁或上腔静脉)消除非 PV 触发因素与改善无心律失常生存有关。